LENZ Therapeutics, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LENZ and other ETFs, options, and stocks.

About LENZ

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. 

CEO
Evert B. Schimmelpennink
CEOEvert B. Schimmelpennink
Employees
42
Employees42
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2013
Founded2013
Employees
42
Employees42

LENZ Key Statistics

Market cap
739.96M
Market cap739.96M
Price-Earnings ratio
-14.90
Price-Earnings ratio-14.90
Dividend yield
—
Dividend yield—
Average volume
244.42K
Average volume244.42K
High today
$26.44
High today$26.44
Low today
$24.89
Low today$24.89
Open price
$26.34
Open price$26.34
Volume
226.02K
Volume226.02K
52 Week high
$38.93
52 Week high$38.93
52 Week low
$14.42
52 Week low$14.42

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LENZ. This list is generated using Robinhood data, and it’s not a recommendation.
CRISPR
Lucid Group
Robinhood Markets
Plug Power
NIO
Intellia Therapeutics
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.